Mar 05, 2025
4C Medical Secures $175M Series D Preferred Stock Financing
Oct 08, 2024
4C Medical's AltaValve System Commences Pivotal Trial Enrollment
May 08, 2024
4C Medical's AltaValve System Secures Dual FDA Breakthrough Device Designations, Expediting Patient Access to Advanced Mitral Valve Therapies
Dec 22, 2020
4C Medical Technologies Announces Completion of a $10 Million Over-Subscribed Convertible Note Financing
Sep 30, 2019
AltaValve(TM), 4C Medical's Novel Transcatheter Mitral Regurgitation Device Highlighted at TCT 2019
Feb 25, 2019
4C Medical's Novel Mitral Regurgitation Therapy to be Highlighted at CRT 2019 Meeting
Sep 13, 2018
4C Medical's AltaValve First In Human Experience to be Presented at TCT 2018
Sep 10, 2018
4C Medical Technologies Announces $17 Million Series A Financing
Mar 07, 2018
4C Medical's Transcatheter Mitral Valve Technology Receives First Place in Cardiovascular Research Technologies 2018 Competition
Mar 01, 2018
4C Medical's Novel Mitral Regurgitation Therapy to be Highlighted at CRT 2018 Meeting
Dec 05, 2017
4C Medical's Novel Transcatheter Mitral Valve Technology Awarded Best Technology Parade Presentation at ICI 2017
Dec 04, 2017
4C Medical's Novel Transcatheter Mitral Valve Technology Presented at ICI 2017 Technology Parade
Nov 02, 2017
4C Medical's Novel Transcatheter Mitral Valve Presented at TCT 2017 Shark Tank Innovation Competition
Oct 24, 2017
4C Medical's Novel Mitral Regurgitation Therapy to be Presented at TCT 2017 Shark Tank Innovation Competition
Aug 03, 2017
4C Medical's Novel Mitral Regurgitation Therapy Highlighted at CVI 2017 Innovation Summit
Jul 19, 2017
4C Medical Exceeds $8 Million Convertible Note Financing Round Led by Anges Québec
Jun 15, 2017
4C Medical's Novel Mitral Regurgitation Therapy Highlighted at TVT Innovation Forum
Jun 08, 2017
4C Medical's Mitral Regurgitation Therapy to be Featured in 2017 TVT Innovation Forum